These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 19515040)

  • 1. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
    Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
    Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muir-Torre syndrome.
    Cohen PR; Kohn SR; Davis DA; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients.
    Joly MO; Attignon V; Saurin JC; Desseigne F; Leroux D; Martin-Denavit T; Giraud S; Bonnet-Dupeyron MN; Faivre L; Auclair J; Grand-Masson C; Audoynaud C; Wang Q
    Hum Mutat; 2015 Mar; 36(3):292-5. PubMed ID: 25504677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
    Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
    Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Muir-Torre syndrome--a phenotypic variant of Lynch syndrome].
    Kacerovská D; Kazakov DV; Cerná K; Hadravský L; Michal M; Dostál J; Skálová A; Michal M
    Cesk Patol; 2010 Oct; 46(4):86-94. PubMed ID: 21313735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muir-Torre syndrome: case report and review of the literature.
    Ang JM; Alai NN; Ritter KR; Machtinger LA
    Cutis; 2011 Mar; 87(3):125-8. PubMed ID: 21488569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
    Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
    Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
    Fernandez-Flores A
    Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muir-Torre syndrome.
    Bhaijee F; Brown AS
    Arch Pathol Lab Med; 2014 Dec; 138(12):1685-9. PubMed ID: 25427047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microsatellite instability, immunohistochemistry and mismatch repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre syndrome.
    Ponti G; Manfredini M; Pellacani G; Tomasi A
    Clin Chem Lab Med; 2016 Nov; 54(11):1725-1731. PubMed ID: 27016151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
    John AM; Schwartz RA
    J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations.
    Ponti G; Ponz de Leon M; Maffei S; Pedroni M; Losi L; Di Gregorio C; Gismondi V; Scarselli A; Benatti P; Roncari B; Seidenari S; Pellacani G; Varotti C; Prete E; Varesco L; Roncucci L
    Clin Genet; 2005 Nov; 68(5):442-7. PubMed ID: 16207212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
    Morales-Burgos A; Sánchez JL; Figueroa LD; De Jesús-Monge WE; Cruz-Correa MR; González-Keelan C; Nazario CM
    P R Health Sci J; 2008 Dec; 27(4):322-7. PubMed ID: 19069357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a cystic sebaceous neoplasm always marker for Muir-Torre syndrome?
    Arsenovic N; Ramaiya A
    Dermatol Online J; 2009 Nov; 15(11):11. PubMed ID: 19951647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muir-Torre syndrome.
    Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
    Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.